Clinical Trial Update: FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (FAST-A) evaluating the efficacy and safety of Quetiapin IR in acute psychosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Quetiapin IR (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Psychotic Disorders, Schizophrenia | Phase 3 | Status: TERMINATED